Guardion Health Sciences, Inc. (GHSI)

NASDAQ: GHSI · IEX Real-Time Price · USD
0.156
-0.011 (-6.60%)
At close: Aug 18, 2022 4:00 PM
0.151
-0.004 (-2.892%)
After-hours: Aug 18, 2022 7:59 PM EDT
-6.60%
Market Cap 9.59M
Revenue (ttm) 11.44M
Net Income (ttm) -21.86M
Shares Out 61.60M
EPS (ttm) -0.88
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 733,692
Open 0.164
Previous Close 0.167
Day's Range 0.155 - 0.165
52-Week Range 0.130 - 1.980
Beta 0.79
Analysts Buy
Price Target 0.69 (+343.4%)
Earnings Date Aug 15, 2022

About GHSI

Guardion Health Sciences, Inc., together with its subsidiaries, operates as a specialty health sciences company in the United States. It operates in two segments, Medical Foods and Nutraceuticals, and Medical Devices. The company offers Lumega-Z, a medical food that replenishes and restores the macular protective pigment; and GlaucoCetin, a vision-specific medical food to support and protect the mitochondrial function of optic nerve cells, as well as improve blood flow in the ophthalmic artery in patients with glaucoma. It also provides MapcatS... [Read more...]

Industry Personal Products
IPO Date Apr 5, 2019
Employees 13
Stock Exchange NASDAQ
Ticker Symbol GHSI
Full Company Profile

Financial Performance

In 2021, GHSI's revenue was $7.23 million, an increase of 282.74% compared to the previous year's $1.89 million. Losses were -$24.75 million, 188.7% more than in 2020.

Financial Statements

Analyst Forecast

According to 8 analysts, the average rating for GHSI stock is "Buy." The 12-month stock price forecast is 0.69, which is an increase of 343.44% from the latest price.

Price Target
$0.69
(343.44% upside)
Analyst Consensus: Buy
Stock Forecasts

News

Guardion Health Sciences Announces Financial Results for the Quarter Ended June 30, 2022

Viactiv® Product Line Contributes to Highest Quarterly Revenue in Company History of Approximately $3.275 Million, Shows Significant Revenue Growth from Prior Quarter Viactiv® Product Line Contributes t...

ISS Recommends Guardion Stockholders Vote for the Increase in Shares for Equity Plan and for the Reverse Stock Split ...

HOUSTON, June 09, 2022 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (“Guardion” or the “Company”) (NASDAQ: GHSI) announced that independent proxy advisory firm ISS recommends that Guardion stockho...

7 Undervalued Penny Stocks to Buy for Massive Gains

These seven undervalued penny stocks each have the potential to pay off for investors down later down the road. The post 7 Undervalued Penny Stocks to Buy for Massive Gains appeared first on InvestorPlace.

Other symbols: CIDMIDEXMUXRMOSENSSHIP

Guardion Health Sciences Announces Agreement with OmegaQuant Laboratories

HOUSTON, June 01, 2022 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (“Guardion” or the “Company”) (Nasdaq: GHSI) announced an agreement with OmegaQuant Laboratories (“OmegaQuant”) to provide Guard...

Guardion Health Sciences Announces New Viactiv Omega Boost Gel Bites Now Available for Purchase on Amazon

Consumers May Now Purchase Viactiv Omega Boost 1,200 mg Omega-3 Gel Bites Directly from Amazon

Guardion Health Sciences Announces Financial Results for the Quarter Ended March 31, 2022

Viactiv® Generated Net Revenues of approximately $2.3 Million or 95% of Net Revenues for the Quarter Ended March 31, 2022 Viactiv® Generated Net Revenues of approximately $2.3 Million or 95% of Net Reve...

Guardion Health Sciences to Present at the Planet MicroCap Showcase 2022

HOUSTON, May 03, 2022 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (Nasdaq: GHSI), a clinical nutrition company that develops clinically supported nutrition, medical foods, and supplements, announ...

Guardion Health Sciences Announces New Viactiv® Omega Boost Gel Bites Now Available for Purchase Via Viactiv® Shopify...

Consumers May Now Purchase Viactiv® Omega Boost Directly from Viactiv.com

Guardion Health Sciences Announces Financial Results for the Year Ended December 31, 2021

June 2021 Acquisition of Viactiv® Brand and Business Changed Operational Focus of Company and Materially Impacted 2021 Revenues, Operations and Financial Results

Guardion Health Sciences to Participate in Fireside Chat at the 34th Annual Roth Conference

HOUSTON, March 11, 2022 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (Nasdaq: GHSI), a clinical nutrition company that develops clinically supported nutrition, medical foods, and supplements, anno...

Guardion Health Sciences, Inc. Announces Closing of $11 Million Public Offering

HOUSTON, Feb. 23, 2022 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (NASDAQ:GHSI) (“Guardion” or the “Company”), a clinical nutrition company that develops clinically supported nutrition, medical ...

Guardion Health Sciences, Inc. Announces Pricing of $11 Million Public Offering

HOUSTON, Feb. 18, 2022 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (NASDAQ:GHSI) (“Guardion” or the “Company”), a clinical nutrition company that develops clinically supported nutrition, medical ...

Guardion Health Sciences Launches New Online Store for Viactiv

New e-commerce venue to offer all Viactiv products and additional educational content to enhance user experience New e-commerce venue to offer all Viactiv products and additional educational content to ...

Guardion Health Sciences to Wind Down VectorVision Business Operations and Focus on Exploiting VectorVision Intellect...

Management Anticipates $300,000+ Reduction in Annual Operating Costs Management Anticipates $300,000+ Reduction in Annual Operating Costs

Guardion Health Sciences Issues Letter to Shareholders

HOUSTON, Dec. 16, 2021 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (“Guardion” or the “Company”) (Nasdaq: GHSI), a clinical nutrition and diagnostics company that develops clinically supported nu...

Guardion Health Sciences Announces Financial Results for the Three Months Ended September 30, 2021

$3,000,000+ Sales from Viactiv® Products During the Quarter $3,000,000+ Sales from Viactiv® Products During the Quarter

GHSI Stock: 12 Things to Know About Guardion Health Science as Shares Rocket

Guardion Health Science (GHSI) stock is taking off on Wednesday thanks to a presentation taking place today and heavy trading. The post GHSI Stock: 12 Things to Know About Guardion Health Science as Sha...

Guardion Health Sciences Stockholders Urged to Vote Their Shares for October 22, 2021 Annual Meeting

HOUSTON, Oct. 12, 2021 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (Nasdaq: GHSI) (“Guardion” or the “Company”), a clinical nutrition and diagnostics company that develops clinically supported nu...

Guardion Health Sciences to Present at the LD Micro Main Event Conference

HOUSTON, Oct. 05, 2021 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (Nasdaq: GHSI) (“Guardion” or the “Company”), a clinical nutrition and diagnostics company that develops clinically supported nu...

Guardion Health Sciences Announces Financial Results for the Three Months Ended June 30, 2021, including $1,000,000+ ...

Corporate Update and Overview of Growth Plans Also Provided Corporate Update and Overview of Growth Plans Also Provided

Guardion Health Sciences to Exhibit at the American Society of Cataract and Refractive Surgery Annual Meeting

SAN DIEGO, July 22, 2021 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (Nasdaq: GHSI) (“Guardion” or the “Company”), a clinical nutrition and diagnostics company that develops clinically supported ...

Acquiring Activ Nutritional Is Perfect for Growth, Says Guardion Health Sciences

Guardion Health Sciences Inc. (NASDAQ: GHSI) is confident that its recent acquisition of Activ Nutritional LLC will be a strong catalyst for growth. The company successfully entered into an equity purch...

Guardion Health Sciences to Be Added to the Russell 3000 Index

SAN DIEGO, June 14, 2021 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (Nasdaq: GHSI) (“Guardion” or the “Company”), a clinical nutrition and diagnostics company that develops clinically supported ...

Guardion Health Sciences Announces Appointment of Craig J. Sheehan as Chief Commercial Officer

Proven Leader of Viactiv Brand to Oversee Ramp Up and Commercial Activities at Guardion Proven Leader of Viactiv Brand to Oversee Ramp Up and Commercial Activities at Guardion

Guardion Health Sciences Broadens Clinical Nutrition Product Offerings by Closing Acquisition of Activ Nutritional, w...

Acquisition to Transform and Strengthen Guardion's  Clinical Nutrition Product Portfolio